|
|
 |
|
Viewing report
|
|
 |
 |
Cardiovascular Disease Diagnostics - Global Strategic Business Report
Global Industry Analysts, Inc., March 2008, Pages: 415
This report analyzes the worldwide markets for Cardiovascular Disease Diagnostics in Millions of US$. The major product segments analyzed are In Vitro Diagnostics, and In Vivo Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 72 companies including many key and niche players worldwide such as Abbott Diagnostics, Biosite, Inc., Cambridge Heart, Inc., Cholestech Corp., Dade Behring, Inc., EP Medsystems, GE HealthCare, Liposcience, Inc., Philips Medical Systems, Roche Diagnostics, and Siemens Medical Solutions. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Cardiovascular Disease Diagnostics - A World Market Intelligence Report
Diabetes, Metabolic Syndrome and Cardiovascular Disease
Blood Biomarkers and Beyond: Biomarker and Diagnostic Opportunities in Cardiovascular Disease
The Top 25 Manufacturers Of Point-Of-Care Diagnostics For Cardiovascular Medicine
Risk Stratification in the Diagnosis of Cardiovascular Disease
Cardiovascular Disease: Current Research, Devices and Drugs
Molecular Diagnostics - Technologies, Markets and Companies
The 2009-2014 Outlook for Cardiovascular Disease (CVD) Diagnostics in India
The 2009-2014 Outlook for Cardiovascular Disease (CVD) Diagnostics in Japan
The 2009-2014 Outlook for Cardiovascular Disease (CVD) Diagnostics in Greater China
The 2009-2014 Outlook for Cardiovascular Disease (CVD) Diagnostics in the United States
The 2009-2014 Outlook for Cardiovascular Disease (CVD) Diagnostics in Asia & Oceana
|
 |
|
|